Kidney Transplantation in Semarang: Outcomes and Prognosis

Authors

  • Eriawan Agung Nugroho Departemen Urologi Fakultas Kedokteran Universitas Diponegoro/RSUP Dr.Kariadi, Indonesia
  • Tommy Supit Departemen Bedah Fakultas Kedokteran Universitas Diponegoro/RSUP Dr.Kariadi, Indonesia
  • Ardy Santosa Departemen Urologi Fakultas Kedokteran Universitas Diponegoro/RSUP Dr.Kariadi, Indonesia
  • Nanda Daniswara Departemen Urologi Fakultas Kedokteran Universitas Diponegoro/RSUP Dr.Kariadi, Indonesia
  • Sofyan Rais Addin Departemen Urologi Fakultas Kedokteran Universitas Diponegoro/RSUP Dr.Kariadi, Indonesia
  • Anggun Ari Mukti Departemen Bedah Fakultas Kedokteran Universitas Diponegoro/RSUP Dr.Kariadi, Indonesia

DOI:

https://doi.org/10.36408/mhjcm.v6i1.381

Abstract

Introduction & objective:Kidney transplantationis increasingly performed acrossIndonesia, including in Semarang. However there are limited publications onrenal transplantationfrom Indonesia, especially from centers outside Jakarta. The objective of this case series is to give a brief overview on the transplantation performed in Semarang, discusscurrent issues and ongoing efforts to address them.

Case series:Twenty-seven renal transplants in Dr. Kariadi General Hospital from January2012 until July 2018wereretrospectively analyzed. On average recipients were younger (32.5 years old) compared to the donors (46.8 years old). All kidneys were acquired from living donors with the majority of them to be blood-related(74.1%). The 3 leading etiologies of end-stage renal disease were hypertension (36.0%), diabetes mellitus (26.9%), and autoimmune disease (11.2%). The average total ischemic time was 36.9 minutes andthe average length of stay was 11 days. We report 5 cases of mortality, 3 cases of allograft rejection and no re-transplantation.

Discussion: The demographics of kidney transplant patients in Semarang were similar compared to the National data. The limited number of transplant in Semarang contributes to the low number of survival rate and highlights the need of further training and expertise. Better survival rate can be achieved with more transplants number as well as reaching the plateau of learning curve within the coming years.

Conclusion: The development of kidney transplant in Semarang follows the National milestones. In order to maximize the potentialthe institution, further improvements should concentrate on the development of integrated organ transplant infrastructure. The main goal of this institution is to establish a solid transplant center capable of covering Central Java, aiding the decentralization of kidney transplant in the Nation

Keywords: Kidney transplantation, End-stage Renal Disease, Chronic Kidney Disease, Indonesia, Semarang, Epidemiology, Update

Downloads

Download data is not yet available.

Additional Files

Published

2019-09-20

How to Cite

1.
Nugroho EA, Supit T, Santosa A, Daniswara N, Addin SR, Mukti AA. Kidney Transplantation in Semarang: Outcomes and Prognosis. Medica Hospitalia J. Clin. Med. [Internet]. 2019 Sep. 20 [cited 2024 Dec. 22];6(1):59-63. Available from: http://medicahospitalia.rskariadi.co.id/medicahospitalia/index.php/mh/article/view/381

Issue

Vol. 6 No. 1 (2019): Med Hosp; Mei 2019

Section

Original Article

Citation Check

License

Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.